Expression of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Flk-1 in Benign, Premalignant, and Malignant Prostate Tissue
Open Access
- 1 July 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (1) , 115-121
- https://doi.org/10.1309/1lbm-6x32-jh6w-enud
Abstract
Vascular endothelial growth factor (VEGF) is one of the most potent mitogenic, highly specific tumor angiogenic factors, which acts via binding to 2Keywords
This publication has 14 references indexed in Scilit:
- Elevated serum vascular endothelial growth factor in patients with hormone‐escaped prostate cancerBJU International, 2000
- Expression of vascular endothelial growth factor receptors in human prostate cancerUrology, 1999
- Angiogenesis in urological malignancy: prognostic indicator and therapeutic targetBJU International, 1999
- Testosterone Stimulates Angiogenesis and Vascular Regrowth in the Ventral Prostate in Castrated Adult Rats1Endocrinology, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989